Biotech

All Articles

Zephyrm finds Hong Kong IPO to finance phase 3 cell therapy trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO...

Frazier Lifestyle Sciences gathers $630M for tiny, mid-cap biotechs

.Frazier Life Sciences has actually sourced a further $630 thousand for its fund concentrated on tin...

GigaGen garners approximately $135M BARDA bucks to beat botulism

.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its technician to ...

GPCR firm Septerna apply for IPO on durability of preclinical information

.Septerna will figure out just how a biotech without "any relevant medical data" meals in the late 2...

Kurma shuts initially $154M payload for most significant biotech fund as yet

.International VC company Kurma Partners has introduced its most recent biotech fund, along with 140...

Prothena markets one director while an additional places-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings an...

Editas capitalize Tip Cas9 licensing civil rights for $57M

.Versus the background of a Cas9 patent war that refuses to perish, Editas Medicine is moneying in a...

Ultragenyx modifies genetics therapy application to dial up efficiency

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson disease gene treatment UX701 ha...

Biopharma discharge fee stabilizes in Q3: Brutal Biotech study

.As summer season warmth looks to cool down winds, wishes that this year would certainly take extens...

J &amp J loses phase 2 dengue applicant in most up-to-date switch from vaccinations

.Johnson &amp Johnson's deprioritization of its transmittable health condition pipeline has actually...